MedTrace Logo

Dyslipidemia Management in Chinese Post Stroke Patients

NCT01897883 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2015-07-30

No results posted yet for this study

Summary

The purpose of this study is to provide current and reliable data of dyslipidimia management together with control situation of blood pressure and glucose for post-stroke patients within 6-12 months from attack, and also the association between patient characteristics and control rate of lipids in this population.

It is an non-interventional study, no study specified treatment is required.Approximately 5000 post ischemic stroke patients within 6-12 months from attack will enter into the study. Fifty centres from different regions of China will participate in this study.

Conditions

  • Brain Ischemia,Stoke

Sponsors & Collaborators

Principal Investigators

  • Yong Jun Wang · Capital Medical University afffiliated Beijing Tiantan Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01897883 on ClinicalTrials.gov